GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » Treasury Stock

Big Pharma Split (TSX:PRM) Treasury Stock : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Big Pharma Split's treasury stock for the quarter that ended in Dec. 2023 was C$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Big Pharma Split Treasury Stock Historical Data

The historical data trend for Big Pharma Split's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Treasury Stock Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Treasury Stock
Get a 7-Day Free Trial - - - - -

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Big Pharma Split Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Big Pharma Split (TSX:PRM) Business Description

Traded in Other Exchanges
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.